LOS ANGELES – Financier Carl Icahn (search) on Friday offered to buy the shares of generic drugmaker Mylan Laboratories (MYL) that he does not already own for $4.9 billion, or $20 a share, according ...

Move over, Martin Shkreli. Get in line, Valeant Pharmaceuticals. Congress appears to have found another drug maker to scold over high prices. Responding to the high cost of the EpiPen auto-injector ...

PITTSBURGH – Generic drug maker Mylan Laboratories Inc. (MYL) is buying branded drug maker King Pharmaceuticals Inc. (KG) for about $4 billion in stock, company officials said Monday. Mylan has ...

WASHINGTON (CBS.MW) -- Mylan Laboratories , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals is in the long-term ...

You can add Mylan Laboratories to the list of drug makers boosting prices by big amounts. Over the past six months, the company, which is one of the world’s largest purveyors of generic medicines, ...

Mylan Labs Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 PITTSBURGH, Sept. 17 -- Mylan Laboratories Inc. (NYSE:MYL) ("Mylan") announced ...

Mylan Laboratories Inc. (MYL) Q1 2010 Earnings Call April 29, 2010 10:00 AM ETExecutivesDan Crookshank - VP, Global IRRobert Coury - Chairman & ...

Has Mylan Laboratories been stichting it to shareholders? This is what several Mylan shareholders claim in a lawsuit in which they argue a complicated maneuver the drug maker pursued to thwart hostile ...

San Antonio’s DPT Laboratories, which manufactures topical medications, will soon be answering to a new parent company — global pharmaceutical company Mylan — if a $1 billion deal closes this fall as ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...